Egis Pharmaceuticals PLC is a Manufacturer/Innovator company operating in the pharmaceutical industry.
Egis Pharmaceuticals PLC is a leading generic pharmaceutical company operating principally in Central and Eastern Europe. The company’s activities incorporate all areas of the pharmaceutical value chain from R&D through production of APIs and finished products to sales and marketing in more than 60 countries. Egis has extensive experience in development of value-added generic molecules, efficient manufacturing processes, robust analytical methods for determination of impurities, comprehensive knowledge of organic chemical reactions and operations and strong IP support.
Company type
Manufacturer/Innovator
Products and services
Finished Dosage Forms, APIs (Active Pharmaceutical Ingredients)
Markets
North America (USA, Canada), Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Address
Egis Pharmaceuticals PLC, Kereszturi ut 30-38, Budapest, Hungary, H-1106
